Southern Research
Southern Research (SR) is a nonprofit preclinical contract research institute that has been bridging basic science and commercial solutions for over 80 years. From pioneering chemotherapy research in collaboration with Memorial Sloan Kettering to generating millions of data points in the global fight against COVID-19, SR has consistently been at the forefront of scientific innovation. Our team of experts excels in transforming cutting-edge science into tangible societal benefits, utilizing comprehensive drug discovery and development capabilities to drive innovation and advance life-saving medical breakthroughs. SR collaborates with over 100 industrial partners, the federal government, and numerous academic institutions to advance the development of life-saving medicines.
Industries
Nr. of Employees
medium (51-250)
Awards
Investigating Methods for Performance Overdrive (IMPROVE)
Markerless Biomechanics To Investigate Performance
Funding (ceiling)
$1,074,956
Award Year
2020
Products
Force-induced treadmill prototype for rehabilitation
Prototype rehabilitation treadmill that applies programmable resistive forces and safety catch mechanisms to enable safe, progressive gait training.
Force-induced treadmill prototype for rehabilitation
Prototype rehabilitation treadmill that applies programmable resistive forces and safety catch mechanisms to enable safe, progressive gait training.
Expertise Areas
- Drug discovery and preclinical development
- Infectious disease and virology research
- Oncology research
- Toxicology and safety assessment
Key Technologies
- High-throughput screening and assay automation
- Medicinal chemistry and synthetic chemistry
- Liquid chromatography–ICP-MS for trace-element speciation
- Inductively coupled plasma mass spectrometry (ICP-MS)
Key People
Doug Bartels
Director, Strategic Initiatives at dbartels@southernresearch.org, 205-581-2738
Rebecca Boohaker
Director, Strategic Initiatives at rboohaker@southernresearch.org, 205-581-2706
Doug Bartels
Director, Strategic Initiatives at dbartels@southernresearch.org, 205-581-2738
Rebecca Boohaker
Director, Strategic Initiatives at rboohaker@southernresearch.org, 205-581-2706
News & Updates
Southern Research has discovered seven FDA-approved anticancer drugs, two of which are on the WHO List of Essential Medicines.
Southern Research was part of a team awarded a $71 million contract to support Redstone Arsenal’s Aviation and Missile Research, Development, and Engineering Center.
Southern Research was awarded two BARDA contracts valued between $45 million and $90 million for nonclinical research services to protect the U.S. against infectious disease and bio-terror threats.
Southern Research annually recognizes outstanding employees for advancing science, technology, and organizational excellence.
Southern Research signed its first licensing agreement in a decade with Bionetix Inc. to develop and potentially commercialize novel epigenetic enzyme inhibitors for cancer therapy.
Southern Research is building a Center for Pandemic Resilience to double lab space for infectious disease research and support Alabama’s biotech corridor.
Southern Research has discovered seven FDA-approved anticancer drugs, two of which are on the WHO List of Essential Medicines.
Southern Research was part of a team awarded a $71 million contract to support Redstone Arsenal’s Aviation and Missile Research, Development, and Engineering Center.
Southern Research was awarded two BARDA contracts valued between $45 million and $90 million for nonclinical research services to protect the U.S. against infectious disease and bio-terror threats.
Southern Research annually recognizes outstanding employees for advancing science, technology, and organizational excellence.
Southern Research signed its first licensing agreement in a decade with Bionetix Inc. to develop and potentially commercialize novel epigenetic enzyme inhibitors for cancer therapy.
Southern Research is building a Center for Pandemic Resilience to double lab space for infectious disease research and support Alabama’s biotech corridor.